Literature DB >> 24932361

The Brockenbrough-Braunwald-Morrow sign.

Alejandro R Trevino1, John Buergler1.   

Abstract

Hypertrophic cardiomyopathy is a relatively common genetic disorder and usually asymptomatic. However, approximately 25% of patients develop left ventricular outflow obstruction and can develop angina, syncope, or congestive heart failure. Initiation and titration of beta-blockade usually results in symptomatic improvement. Patients with medically refractory symptoms can see further symptomatic improvement and relief of obstruction with either surgical myectomy or alcohol septal ablation (ASA). Although surgical myectomy has been the gold standard, ASA has been shown in nonrandomized studies and a meta-analysis to be comparable. In patients undergoing ASA without a rest obstruction, the Brokenbrough-Braunwald-Morrow sign can be used to accurately determine the degree of left ventricular outflow tract (LVOT) obstruction prior to, during, and after ASA.

Entities:  

Keywords:  Brockenbrough-Braunwald-Morrow sign; alcohol septal ablation; hypertrophic cardiomyopathy

Mesh:

Substances:

Year:  2014        PMID: 24932361      PMCID: PMC4051332          DOI: 10.14797/mdcj-10-1-34

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  19 in total

1.  Hemodynamic rounds series II: hemodynamic effects of alcohol-induced septal infarction for hypertrophic obstructive cardiomyopathy.

Authors:  M J Kern; H Rajjoub; R Bach
Journal:  Catheter Cardiovasc Interv       Date:  1999-06       Impact factor: 2.692

2.  Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy.

Authors:  S F Nagueh; S R Ommen; N M Lakkis; D Killip; W A Zoghbi; H V Schaff; G K Danielson; M A Quiñones; A J Tajik; W H Spencer
Journal:  J Am Coll Cardiol       Date:  2001-11-15       Impact factor: 24.094

3.  Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery.

Authors:  J X Qin; T Shiota; H M Lever; S R Kapadia; M Sitges; D N Rubin; F Bauer; N L Greenberg; D A Agler; J K Drinko; M Martin; E M Tuzcu; N G Smedira; B Lytle; J D Thomas
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

4.  Studies on digitalis. V. Comparison of the effects of ouabain on left ventricular dynamics in valvular aortic stenosis and hypertrophic subaortic stenosis.

Authors:  E BRAUNWALD; E C BROCKENBROUGH; R L FRYE
Journal:  Circulation       Date:  1962-08       Impact factor: 29.690

5.  Images in clinical medicine. Pressure tracings in obstructive cardiomyopathy.

Authors:  S G Pollock
Journal:  N Engl J Med       Date:  1994-07-28       Impact factor: 91.245

Review 6.  Hypertrophic cardiomyopathy. Clinical spectrum and treatment.

Authors:  E D Wigle; H Rakowski; B P Kimball; W G Williams
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

Review 7.  Hypertrophic cardiomyopathy.

Authors:  B J Maron
Journal:  Lancet       Date:  1997-07-12       Impact factor: 79.321

Review 8.  Hypertrophic cardiomyopathy: a systematic review.

Authors:  Barry J Maron
Journal:  JAMA       Date:  2002-03-13       Impact factor: 56.272

9.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Iacopo Olivotto; Sandro Betocchi; Susan A Casey; John R Lesser; Maria A Losi; Franco Cecchi; Barry J Maron
Journal:  N Engl J Med       Date:  2003-01-23       Impact factor: 91.245

10.  Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy.

Authors:  D R Rosing; U Idänpään-Heikkilä; B J Maron; R O Bonow; S E Epstein
Journal:  Am J Cardiol       Date:  1985-01-25       Impact factor: 2.778

View more
  3 in total

1.  Gradient variability in hypertrophic cardiomyopathy: New insights from computer-assisted, high fidelity, rest and exercise hemodynamic analysis.

Authors:  Terry D Bauch; Alexandra J Smith; Joseph P Murgo; James A Watts; Bernard J Rubal
Journal:  Catheter Cardiovasc Interv       Date:  2018-11-25       Impact factor: 2.692

2.  Brockenbrough-Braunwald-Morrow Sign: An Evaluative Hemodynamic Maneuver for Left Ventricular Outflow Tract Obstruction.

Authors:  Glenmore Lasam
Journal:  Cardiol Res       Date:  2018-06-06

3.  Hypertrophic Cardiomyopathy and the Brockenbrough-Braunwald-Morrow Phenomenon: A Case Report.

Authors:  Alexa Bello; Jose L Diaz; Taylor P Travis; Joseph Varon; Salim R Surani
Journal:  Cureus       Date:  2019-10-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.